For the Quarter Ending March 2026
Loperamide Hydrochloride Prices in North America
- In USA, the Loperamide Hydrochloride Price Index rose by 1.94% quarter-over-quarter, reflecting weaker freight and demand moderation.
- The average Loperamide Hydrochloride price for the quarter was approximately USD 138600.00/MT on a CFR basis.
- Lower ocean freight reduced landed costs while the Loperamide Hydrochloride Spot Price remained range bound amid ample supply.
- Regulatory inspections lengthened lead times, influencing the Loperamide Hydrochloride Price Forecast and prompting precautionary importer restocking.
- Stable feedstock availability limited Loperamide Hydrochloride Production Cost Trend pressure despite occasional freight and insurance increases from geopolitical risks.
- Downstream retail and hospital buying patterns shaped the Loperamide Hydrochloride Demand Outlook, with formulators keeping inventories light.
- The Loperamide Hydrochloride Price Index showed monthly volatility driven by freight swings and inspection-related shipment delays.
- Importers maintained conservative procurement strategies, dampening short-term upside while supporting measured market stabilization near term.
Why did the price of Loperamide Hydrochloride change in March 2026 in North America?
- Freight rates rose significantly on South Asia United States lanes, increasing CFR landed costs and lifting invoice prices.
- Regulatory documentation reviews extended release timelines, tightening prompt supply and prompting buyers to rebuild safety stocks.
- Retailers increased replenishment ahead of spring travel and norovirus activity, boosting immediate downstream demand versus February.
Loperamide Hydrochloride Prices in APAC
- In China, the Loperamide Hydrochloride Price Index rose by 1.98% quarter-over-quarter, reflecting tighter import availability.
- The average Loperamide Hydrochloride price for the quarter was approximately USD 138503.33/MT, CFR Shanghai import-weighted.
- Short-term Loperamide Hydrochloride Spot Price strengthened in March as European cargo delays reduced near-term availability.
- Loperamide Hydrochloride Price Forecast points to modest gains as constrained imports meet steady downstream requirements.
- Loperamide Hydrochloride Production Cost Trend rose modestly due to higher freight and compliance-related origin premiums.
- Loperamide Hydrochloride Demand Outlook remained muted with formulators preferring routine procurement over speculative inventory strategies.
- Inventory declines at Shanghai bonded warehouses supported the Loperamide Hydrochloride Price Index tightening near-term availability.
- Indian suppliers remained while European GMP audits delayed cargoes, prompting short-term sourcing shifts toward India.
Why did the price of Loperamide Hydrochloride change in March 2026 in APAC?
- European GMP inspections delayed shipments reducing import supply and prompting immediate March price increases significantly.
- A 0.7 percent freight uptick on India-China routes raised landed costs, feeding into CFR quotations.
- Steady domestic offtake meant limited demand growth, so supply disruptions disproportionately influenced March pricing outcomes.
Loperamide Hydrochloride Prices in Europe
- In Germany, France, and the UK, the Loperamide Hydrochloride Price Index fell by 1.8% quarter-over-quarter, pressured by sluggish generic tenders and abundant warehoused supply.
- The Loperamide Hydrochloride Spot Price traded quietly, with few spot inquiries as most buyers fulfilled requirements via existing annual contracts.
- Lower natural gas and electricity prices in the EU slightly reduced manufacturing overheads, easing the Loperamide Hydrochloride Production Cost Trend.
- The Loperamide Hydrochloride Price Forecast remains flat to slightly negative due to ongoing generic competition and centralized procurement policies.
- The Loperamide Hydrochloride Demand Outlook showed weakness as OTC sales normalized following the winter gastrointestinal season.
- Some Southern European distributors attempted small price increases, but Northern European buyers resisted, keeping the regional index range-bound.
- GMP re-inspections of Indian facilities caused intermittent shipment alerts, yet overall availability remained sufficient to prevent price recovery.
Why did the price of Loperamide Hydrochloride change in March 2026 in Europe?
- Prices decreased in March 2026 as post-winter demand lull coincided with the arrival of previously delayed container shipments, increasing prompt supply.
- A major German generic tender was awarded at lower price points, setting a bearish benchmark for the month.
- Euro appreciation against the USD reduced import costs for euro-denominated buyers, further lowering landed prices.
For the Quarter Ending December 2025
Loperamide Hydrochloride Prices in North America
- Loperamide Hydrochloride Spot Price in North America showed moderate fluctuations through the quarter, with the Price Index reflecting steady demand from the pharmaceutical sector.
- The Loperamide Hydrochloride Price Forecast for the region remained cautiously optimistic due to stable feedstock availability and consistent downstream consumption.
Why did the Price Index increase in North America during December 2025?
- The Price Index increased due to higher procurement costs for key intermediates, reduced domestic supply, and increased purchasing activity from OTC drug manufacturers preparing for early-year production cycles.
- The Loperamide Hydrochloride Production Cost Trend indicated slight upward pressure due to increased energy and logistics costs across the U.S. and Canada.
- The Loperamide Hydrochloride Demand Outlook remained strong, supported by robust consumption in generic drug formulations and stable export inquiries.
Loperamide Hydrochloride Prices in Europe
- Loperamide Hydrochloride Spot Price in Europe remained relatively stable early in the quarter, with the Price Index showing mild volatility due to fluctuating feedstock imports.
- The Loperamide Hydrochloride Price Forecast for Europe pointed toward marginal increases, supported by improving pharmaceutical production rates in Germany, France, and the U.K.
Why did the Price Index decrease in Europe during December 2025?
- The Price Index decreased because imported raw material availability improved, freight rates eased, and downstream pharmaceutical production temporarily slowed during the year-end period.
- The Loperamide Hydrochloride Production Cost Trend showed a downward shift as energy prices in the EU stabilized and supply chains normalized.
- The Loperamide Hydrochloride Demand Outlook remained balanced, with steady consumption from both domestic and export-oriented pharmaceutical companies.
Loperamide Hydrochloride Prices in APAC
- Loperamide Hydrochloride Spot Price in APAC displayed notable movement, with the Price Index rising sharply early in the quarter due to strong regional demand.
- The Loperamide Hydrochloride Price Forecast suggested continued firmness, supported by high production activity in China and India.
Why did the Price Index increase in APAC during December 2025?
- The Price Index increased due to supply tightness in China, strong export demand from Southeast Asia, and rising costs of chemical precursors used in Loperamide Hydrochloride synthesis.
- The Loperamide Hydrochloride Production Cost Trend moved upward as raw material prices and environmental compliance costs increased across major APAC manufacturing hubs.
- The Loperamide Hydrochloride Demand Outlook remained bullish, with strong pharmaceutical manufacturing growth and expanding OTC drug consumption.
For the Quarter Ending September 2025
Loperamide Hydrochloride Prices in North America
- In United States, the Loperamide Hydrochloride Price Index rose quarter-over-quarter in Q3 2025, driven by escalating production costs.
- Production costs increased due to a 2.6% PPI rise in August 2025 and tariffs on imported Active Pharmaceutical Ingredients.
- Loperamide Hydrochloride demand was supported by a 5.42% increase in retail sales in September 2025.
- Consumer spending on OTC medications remained robust, despite declining consumer confidence to 94.2 in September 2025.
- Raw material inventories for US chemical manufacturers contracted in Q3 2025, impacting supply dynamics.
- US pharmaceutical exports decreased in July 2025, while imports increased.
- The Biotech and Pharma Market Performance showed a firm trajectory in Q3 2025, supporting sector stability.
Why did the price of Loperamide Hydrochloride change in September 2025 in North America?
- Production costs rose from a 2.6% PPI increase in August 2025 and new API tariffs.
- Strong consumer demand for OTC drugs was supported by a 5.42% retail sales increase in September 2025.
- Contracting raw material inventories and increased industrial electricity prices in September 2025 impacted supply.
Loperamide Hydrochloride Prices in APAC
- In China, the Loperamide Hydrochloride Price Index fell quarter-over-quarter in Q3 2025, driven by deflationary pressures and weak domestic demand.
- Loperamide Hydrochloride production costs declined in Q3 2025, as PPI fell -2.3% year-on-year in September 2025.
- Demand faced headwinds from a 5.2% unemployment rate and 89.6 consumer confidence in September 2025.
- Despite economic moderation, China's pharmaceutical market experienced robust growth in Q3 2025, driven by an aging population.
- Manufacturing Index was Contracting in September 2025, yet industrial production expanded 6.5% year-on-year.
- Elevated global petrochemical oversupply and China's crude inventories built up in Q3 2025.
- China's total exports and imports rose in Q3 2025, with pharmaceutical and API exports growing strongly.
- Global overcapacity in chemical building blocks persisted in Q3 2025, prompting efforts to address sector oversupply.
Why did the price of Loperamide Hydrochloride change in September 2025 in APAC?
- Deflationary pressures from a -0.3% CPI year-on-year in September 2025 dampened consumer demand.
- Weak industrial demand, reflected by -2.3% PPI year-on-year in September 2025, lowered production costs.
- Contracting Manufacturing Index in September 2025 and persistent global overcapacity influenced supply-demand balance.
Loperamide Hydrochloride Prices in Europe
- In Germany, the Loperamide Hydrochloride Price Index remained upward quarter-over-quarter in Q3 2025, amidst conflicting cost and demand pressures.
- Loperamide Hydrochloride production costs faced upward pressure from elevated energy and raw material expenses in Q3 2025.
- Demand for Loperamide Hydrochloride was supported by a moderately growing pharmaceutical market in Q3 2025.
- Germany's Manufacturing Index contracted in Q3 2025, and industrial production declined 1.0% in September 2025.
- Capacity utilization dropped in September 2025, while German chemical exports declined in Q3 2025 due to US tariffs.
- The Consumer Price Index rose 2.4% in September 2025, contributing to general inflationary pressures on raw materials.
- Producer prices of industrial products declined 1.7% in September 2025, primarily due to lower energy prices.
Why did the price of Loperamide Hydrochloride change in September 2025 in Europe?
- Production costs faced upward pressure from a 2.4% CPI rise in September 2025.
- Lower producer prices, down 1.7% in September 2025, eased some production cost burdens.
- Demand was supported by stable retail sales, up 0.2% in September 2025, and pharmaceutical growth.
